AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+48.83%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$3.88B
(+32%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
74.76%
Holding
127
New
34
Increased
29
Reduced
17
Closed
18
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$65.1M |
| 2 |
Arrowhead Research
ARWR
|
$57.4M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$29.5M |
| 4 |
Vera Therapeutics
VERA
|
$21.8M |
| 5 |
Solid Biosciences
SLDB
|
$21.2M |
Top Sells
| 1 |
CAVA Group
CAVA
|
$385M |
| 2 |
Cytokinetics
CYTK
|
$49.6M |
| 3 |
argenx
ARGX
|
$44.3M |
| 4 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$14.8M |
| 5 |
Natera
NTRA
|
$12.5M |
Sector Composition
| 1 | Healthcare | 50.84% |
| 2 | Consumer Discretionary | 48.42% |
| 3 | Technology | 0.53% |
| 4 | Real Estate | 0.1% |
| 5 | Financials | 0.05% |
